Keywords: Biosimilars, USA, Europe, Clinical data, Decision Resources

US and European physicians wary of using biosimilars without clinical data backing

Article | 30 August 2011

The majority of US and European physicians are wary of using a biosimilar for an indication for which supporting clinical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in